Collectively, our findings highlight the potential of targeting PHLPP1 as a therapeutic node to mitigate neuroinflammation and protect dopaminergic neurons in PD, opening new avenues for future research and intervention strategies. Here, PHLPP1 is linked to Parkinson disease.